Translational Hearing Center

转化听力中心

• 批准号: 10579956
• 负责人: Peter Stephen Steyger
• 金额: $ 211.6万
• 依托单位: CREIGHTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-03-05 至 2026-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10579956
• 关键词: Academic Medical Centers; Academic achievement; Acceleration; Achievement; Address; Admission activity; Advisory Committees; Affect; Aging; Attenuated; Auditory; Auditory Perception; Award; Basic Science; Biological Assay; Biomedical Research; Biometry; Center for Translational Science Activities; Centers of Research Excellence; Child; Cities; Clinical; Clinical Investigator; Clinical Research; Clinical Trials; Complement; Development; Drug Delivery Systems; Drug Prescriptions; Drug Screening; Economic Burden; Eligibility Determination; Ensure; Environment; Etiology; Evaluation Research; Exposure to; Fetal Alcohol Spectrum Disorder; Fostering; Foundations; Functional disorder; Funding; Funding Mechanisms; Future; Genetic Polymorphism; Genomics; Goals; Grant; Great Plains; Health; Health system; Hearing; Hearing problem; Hospitals; Human; Impaired cognition; Income; Individual; Infant; Inflammation; Infrastructure; Institution; International; Intervention; Investigation; Investigational Drugs; Investigational New Drug Application; Labyrinth; Language; Lead; Life; Longevity; Malignant Neoplasms; Medical; Medical center; Mental Depression; Mentors; Mentorship; Military Personnel; Mitochondria; Multicenter Studies; Nebraska; Neonatal Intensive Care Units; Neural Pathways; Noise; Noise-Induced Hearing Loss; Occupational; Peripheral; Persons; Pharmacologic Substance; Phase; Pilot Projects; Population; Production; Quality of life; Recreation; Rehabilitation therapy; Research; Research Activity; Research Personnel; Research Project Grants; Risk; Secure; Sensory; Services; Social Interaction; Study Section; System; Technology; Therapeutic; Therapeutic Intervention; Translating; Translational Research; Translations; Universities; Withdrawal; aging population; base; boys; candidate identification; candidate validation; career; cisplatin induced hearing loss; clinical center; drug discovery; efficacy study; efficacy validation; fall risk; hearing impairment; hearing loss phenotype; hearing loss risk; hearing preservation; hearing restoration; high risk; lead candidate; multidisciplinary; neonate; ototoxicity; patient population; pharmacologic; preclinical study; preservation; programs; psychosocial; recruit; safety study; skills; social; socioeconomics; success; therapeutic candidate; translational scientist; voucher; working group

PROJECT SUMMARY/ABSTRACT Overall Plan for the Translational Hearing Center This Center of Biomedical Research Excellence (COBRE) application is to establish the Translational Hearing Center, administered by centrally-located Creighton University, with Boys Town National Research Hospital (BTNRH) and the University of Nebraska Medical Center (UNMC), as institutional partners. Our overall goal is to build a critical mass of academic translational researchers developing therapeutic interventions to preserve or restore hearing and vestibular function from a wide range of etiologies that cause hearing loss and vestibular deficits. Hearing loss in infants and children results in delayed acquisition of listening and spoken language skills critical for academic achievement and maximal career trajectories of affected individuals. In the aging population, hearing loss and vestibular deficits without appropriate rehabilitation accelerates aging and cognitive decline. Aim 1: Develop the infrastructure and expertise base for translational auditory and vestibular research. COBRE funding will enable an Administrative Core within the Center to provide a unique, transformational research environment for junior investigators to translate their basic science discoveries into therapeutic strategies that preserve or restore hearing and vestibular function. This will establish a broader nonclinical research program. The Administrative Core will coordinate interactions between project leaders with their Mentors, and an External Advisory Committee. The Administrative Core will develop a Drug Discovery and Delivery Core that will coordinate necessary drug screen assays and production of derivatives of lead compounds and their delivery to the inner ear and associated central neural pathways, as well as an Auditory Vestibular Technology Core to validate the efficacy of lead candidate ototherapeutics hits. Aim 2: Build a critical mass of funded investigators leading translational auditory and vestibular research. We will examine both peripheral and central mechanisms of hearing loss and vestibular dysfunction, and identify pharmacotherapeutic strategies preserve or restore hearing and vestibular function, with multiple levels of research funding for investigators. We also have an outstanding Mentoring Plan for project leaders, complementing their expertise with senior investigations as Internal Mentors and biostatistical support, as well as outside investigators with translational and clinical expertise as External Mentors. Additional mentoring is provided by Research Core staff, grantsmanship classes and Mock Study Sections of proposals prior to review. Evaluations of research progress, and all other Center activities, are also key to optimize Center success. The Center will also benefit from the burgeoning translational research environment in Omaha, Nebraska. Future plans call for continued expansion of the Center to include submission of Investigational New Drug applications, safety and efficacy studies and clinical trials in partnership with patient populations served by Creighton University’s academic medical center, Catholic Health Initiatives (CHI) Health system, BTNRH and UNMC.

项目总结/摘要 翻译听证中心总体规划 这个生物医学研究卓越中心（COBRE）的应用是建立翻译听证会 中心，由位于市中心的克雷顿大学管理，与男孩镇国家研究医院 （BTNRH）和内布拉斯加大学医学中心（UNMC），作为机构合作伙伴。我们的总体目标是 建立一个临界质量的学术翻译研究人员开发治疗干预措施，以保护或 恢复听力和前庭功能，从广泛的病因，造成听力损失和前庭 赤字婴儿和儿童的听力损失导致听力和口语技能的延迟获得 对受影响个人的学业成就和最大职业轨迹至关重要。在老龄化人口中， 听力损失和前庭缺陷而没有适当的康复会加速衰老和认知能力下降。 目标1：发展基础设施和专业知识基础的翻译听觉和前庭研究。 COBRE的资助将使中心内的行政核心能够提供一个独特的、变革性的 初级研究人员将他们的基础科学发现转化为治疗的研究环境 保护或恢复听力和前庭功能的策略。这将建立更广泛的非临床 研究计划。行政核心将协调项目负责人与其 导师和外部咨询委员会。行政核心将开发药物发现， 交付核心将协调必要的药物筛选试验和铅衍生物的生产 本发明涉及化合物及其向内耳和相关中枢神经通路的递送，以及听觉系统。 前庭技术核心，以验证领先的候选耳治疗命中的疗效。 目标2：建立一个关键质量的资助研究人员领导翻译听觉和前庭 research.我们将研究听力损失和前庭功能障碍的外周和中枢机制， 并确定保留或恢复听力和前庭功能的药物治疗策略， 研究人员的研究经费水平。我们还为项目负责人制定了出色的指导计划， 作为内部导师和生物统计支持， 作为具有翻译和临床专业知识的外部研究者作为外部导师。额外的指导是 由研究核心工作人员，granonymous类和模拟研究部分提供的建议，在审查之前。 对研究进展和所有其他中心活动的评估也是优化中心成功的关键。 该中心还将受益于内布拉斯加州奥马哈蓬勃发展的转化研究环境。未来 计划要求继续扩大该中心，以包括提交研究性新药申请， 与Creighton服务的患者人群合作开展的安全性和有效性研究以及临床试验 大学的学术医疗中心，天主教健康倡议（CHI）卫生系统，BTNRH和UNMC。